Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery.

OBJECTIVE To evaluate the synergistic effect of bone morphogenetic protein 2 (BMP-2) and vascular endothelial growth factor (VEGF) on the repair of bone defects around dental implants. MATERIAL AND METHODS Five groups of scaffold were fabricated by a freeze-drying method, including pure chitosan/collagen scaffold; scaffold loaded with adenoviruses expressing BMP-2, adenoviruses expressing VEGF, both adenoviruses expressing BMP-2 and VEGF, VEGF protein and adenovirus expressing BMP-2. In vitro studies examined whether bone marrow stromal cells were responsive to these scaffolds over time. Bone formation capacity, bone-to-implant contact, as well as removal torque values were investigated in vivo. Differences between the various groups were statistically analyzed using the one-way analysis of variance test. RESULTS The in vitro study revealed a burst and rapid release of VEGF with a sustained high-level expression of BMP-2 in scaffold combined with VEGF protein and adenoviruses expressing BMP-2. Histomorphometry demonstrated that scaffolds expressing BMP-2 enhanced more bone formation compared with other groups; VEGF alone is insufficient to promote bone formation. New bone formation in the bone defects around dental implants, bone-to-implant contact and mean peak removal torque showed statistically significant difference for the adenoviral vector encoding human bone morphogenetic protein 2 (Ad-BMP-2) and VEGF protein and adenovirus expressing BMP-2 groups. Furthermore, scaffold combined with VEGF protein and Ad-BMP-2 represented the best outcomes in this model. CONCLUSIONS A combination of BMP-2 gene and VEGF protein could have a synergistic effect in promoting bone healing.

[1]  D. Kracht,et al.  Vertical ridge augmentation using polylactic membranes in conjunction with immediate implants in periodontally compromised extraction sites: an experimental study in dogs. , 1997, The International journal of oral & maxillofacial implants.

[2]  P. Alberius,et al.  Maxillary alveolar ridge augmentation with onlay bone-grafts and immediate endosseous implants. , 1992, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[3]  G. Daculsi,et al.  Alveolar bone regeneration for immediate implant placement using an injectable bone substitute: an experimental study in dogs. , 2004, Journal of periodontology.

[4]  D. Mooney,et al.  Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  H. Heneghan,et al.  Use of autologous bone graft in anterior cervical decompression: morbidity & quality of life analysis , 2009, BMC musculoskeletal disorders.

[6]  Lazzara Rj,et al.  Immediate implant placement into extraction sites: surgical and restorative advantages. , 1989 .

[7]  Wei Zhang,et al.  The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chitosan/collagen scaffolds. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[8]  H Winet,et al.  The role of microvasculature in normal and perturbed bone healing as revealed by intravital microscopy. , 1996, Bone.

[9]  E. Reynolds,et al.  A prospective clinical study of bone augmentation techniques at immediate implants. , 2005, Clinical oral implants research.

[10]  M. Berridge,et al.  Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. , 1993, Archives of biochemistry and biophysics.

[11]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Gunasekaran Kumar,et al.  Morbidity at Bone Graft Donor Sites , 2014 .

[13]  M. Ueda,et al.  Immunohistochemical study of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2, -4 (BMP-2, -4) on lengthened rat femurs. , 2005, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[14]  Xiangrong Cheng,et al.  Combination of scaffold and adenovirus vectors expressing bone morphogenetic protein-7 for alveolar bone regeneration at dental implant defects. , 2007, Biomaterials.

[15]  R. Carano,et al.  Angiogenesis and bone repair. , 2003, Drug discovery today.

[16]  W. Becker,et al.  A prospective clinical trial of endosseous screw-shaped implants placed at the time of tooth extraction without augmentation. , 1998, Journal of periodontology.

[17]  Andreas Sewing,et al.  Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation. , 2005, Clinical oral implants research.

[18]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[19]  K. Suzuki,et al.  Effects of surface roughness of titanium implants on bone remodeling activity of femur in rabbits. , 1997, Bone.

[20]  D. Ribatti.  The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review , 2005, British journal of haematology.

[21]  Antonios G Mikos,et al.  Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. , 2008, Bone.

[22]  Milica Radisic,et al.  Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. , 2008, Acta biomaterialia.

[23]  F. Schwarz,et al.  Guided bone regeneration using rhGDF-5- and rhBMP-2-coated natural bone mineral in rat calvarial defects. , 2009, Clinical oral implants research.

[24]  B. Zheng,et al.  The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. , 2009, Tissue engineering. Part A.

[25]  Michael J Yaszemski,et al.  Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.

[26]  Jiawei Wang,et al.  Novel chitosan/collagen scaffold containing transforming growth factor-beta1 DNA for periodontal tissue engineering. , 2006, Biochemical and biophysical research communications.

[27]  S. Ylä-Herttuala,et al.  Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ , 2002, The journal of gene medicine.

[28]  Johnny Huard,et al.  Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.

[29]  Antonios G Mikos,et al.  Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. , 2009, Tissue engineering. Part A.

[30]  Kanji Sato,et al.  Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. , 1997, Endocrinology.

[31]  J. Harmey,et al.  Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF) , 2005, Journal of cellular and molecular medicine.

[32]  G. Gagnon,et al.  Activation of human platelet-rich plasmas: effect on growth factors release, cell division and in vivo bone formation. , 2007, Clinical oral implants research.

[33]  N P Lang,et al.  The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment. , 1997, Clinical oral implants research.

[34]  Li-Xin Xiang,et al.  Bone morphogenetic protein. , 2007, Biochemical and biophysical research communications.

[35]  W. Puhl,et al.  Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. , 2002, Bone.

[36]  Richard O C Oreffo,et al.  The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. , 2010, Biomaterials.

[37]  Xiangrong Cheng,et al.  A platelet-derived growth factor releasing chitosan/coral composite scaffold for periodontal tissue engineering. , 2007, Biomaterials.

[38]  Shohei Kasugai,et al.  Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. , 2008, Journal of pharmacological sciences.

[39]  R Casellini,et al.  Tissue preservation and maintenance of optimum esthetics: a clinical report. , 2000, The International journal of oral & maxillofacial implants.

[40]  Kitichai Rungcharassaeng,et al.  Immediate placement and provisionalization of maxillary anterior single implants: 1-year prospective study. , 2003, The International journal of oral & maxillofacial implants.

[41]  C. A. Dunn,et al.  BMP gene delivery for alveolar bone engineering at dental implant defects. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  R. Jung,et al.  Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2. , 2005, Clinical oral implants research.